Biopharma must step up amidst growing oncology market.
William Smith
Advertisement
Management Consultant, RxC International
Articles by William Smith
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
M&A Roundup: McKesson to Acquire Precision Medicine Group, Lundbeck & Eversana Enter AI-Powered Partnership
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
5